ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "David Baram: Founder and CEO of EmendoBio"
Episode Synopsis
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
More episodes of the podcast BioBoss
Welcome to Season 8 of BioBoss
20/12/2025
Michael Cloonan: CEO of Sionna Therapeutics
22/11/2025
Erik van den Berg: CEO of Memo Therapeutics
27/10/2025
Todd Harris: CEO of Tyra Biosciences
30/08/2025
Eduardo Bravo: CEO of Citryll
26/07/2025
Abbas Kazimi: CEO of Nimbus Therapeutics
28/06/2025
Derek Adams: CEO of Stellular Bio
24/05/2025
In God we trust